Additionally, individuals with NF1 occasionally develop pheochromocytomas and leukemias, most commonly myeloid leukemia and juvenile myelomonocytic leukemia (JMML), all of which are driven by aberrant RAS activity. This evidence concerns the gene NF1 and pheochromocytoma.